Facial Injectable Companies

Top Industry Leaders in the Facial Injectable Market

Facial Injectable Key Companies Latest Facial injectables Companies Update

May 2023: U.S. Food and Drug Administration clearance of SKINVIVE by JUVÉDERM to enhance the smoothness of the skin on the cheeks in people over the age of 21.1 was announced by Allergan Aesthetics, a division of AbbVie (NYSE: ABBV). Smoother skin may be yours in as little as one treatment with SKINVIVETM by JUVÉDERM, the first and only hyaluronic acid (HA) intradermal microdroplet injection accessible in the United States. Smooth and injectable HA gel, SKINVIVE by JUVÉDERM has a minimal dose of local anesthetic (lidocaine). Unlike other facial injectables that enhance and enlarge the treated region, SKINVIVE by JUVÉDERM improves skin quality in the cheeks by smoothing the skin and boosting moisture. SKINVIVE by JUVÉDERM fills a significant void in the skin quality market with its specially formulated, silky, moisturizing gel that sinks in quickly and is safe for all Fitzpatrick Skin Types I-VI, from the fairest to the darkest.

March 2023: Galderma announced today the debut of FACE by Galderma™, a breakthrough aesthetic visualization tool powered by augmented reality (AR) that allows aesthetic experts and patients to view injectable treatment results* at the planning stage before treatment begins. This novel approach provides patients with a virtual "before and after" picture of their potential treatment outcomes, which can help allay their fears regarding injectable results. Patients may get a sneak peek at how injectable treatments like Restylane and Sculptra could improve or restore face characteristics with the real-time, simulated outcomes function.

List of Facial injectables Key companies in the market